Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
≥ 32 33 32 33 O
1000 34 38 34 38 B-lower_bound
/ 38 39 38 39 I-lower_bound
mm3 39 42 39 42 I-lower_bound

Antibiotics 0 11 43 54 B-treatment
( 12 13 55 56 I-treatment
ABX 13 16 56 59 I-treatment
) 16 17 59 60 I-treatment
of 18 20 61 63 O
the 21 24 64 67 O
aminoglycoside 25 39 68 82 B-treatment
group 40 45 83 88 I-treatment
( 46 47 89 90 O
ie 47 49 90 92 O
, 49 50 92 93 O
streptomycin 51 63 94 106 B-treatment
, 63 64 106 107 O
gentamicin 65 75 108 118 O
) 75 76 118 119 O
; 76 77 119 120 O
except 78 84 121 127 O
those 85 90 128 133 O
who 91 94 134 137 O
are 95 98 138 141 O
skin 99 103 142 146 O
- 103 104 146 147 O
test 104 108 147 151 O
negative 109 117 152 160 O
for 118 121 161 164 O
gentamicin 122 132 165 175 O
hypersensitivity 133 149 176 192 O

Any 0 3 193 196 O
component 4 13 197 206 O
of 14 16 207 209 O
the 17 20 210 213 O
LN-144 21 27 214 220 O
infusion 28 36 221 229 O
product 37 44 230 237 O
formulation 45 56 238 249 O
including 57 66 250 259 O
dimethyl 67 75 260 268 B-treatment
sulfoxide 76 85 269 278 I-treatment
( 86 87 279 280 I-treatment
DMSO 87 91 280 284 I-treatment
) 91 92 284 285 I-treatment
, 92 93 285 286 O
human 94 99 287 292 O
serum 100 105 293 298 O
albumin 106 113 299 306 O
( 114 115 307 308 O
HSA 115 118 308 311 O
) 118 119 311 312 O
, 119 120 312 313 O
IL-2 121 125 314 318 O
, 125 126 318 319 O
and 127 130 320 323 O
dextran-40 131 141 324 334 B-treatment

At 0 2 335 337 O
least 3 8 338 343 O
one 9 12 344 347 B-lower_bound
measurable 13 23 348 358 O
target 24 30 359 365 O
lesion 31 37 366 372 O
, 37 38 372 373 O
as 39 41 374 376 O
defined 42 49 377 384 O
by 50 52 385 387 O
RECIST 53 59 388 394 O
v1.1 60 64 395 399 O

At 0 2 400 402 O
least 3 8 403 408 O
one 9 12 409 412 O
resectable 13 23 413 423 O
lesion 24 30 424 430 B-chronic_disease
( 31 32 431 432 O
or 32 34 432 434 O
aggregate 35 44 435 444 O
of 45 47 445 447 O
lesions 48 55 448 455 B-chronic_disease
resected 56 64 456 464 O
) 64 65 464 465 O
of 66 68 466 468 O
a 69 70 469 470 O
minimum 71 78 471 478 O
1.5 79 82 479 482 B-lower_bound
cm 83 85 483 485 I-lower_bound
in 86 88 486 488 I-lower_bound
diameter 89 97 489 497 I-lower_bound
post 98 102 498 502 O
- 102 103 502 503 O
resection 103 112 503 512 O
to 113 115 513 515 O
generate 116 124 516 524 O
TIL 125 128 525 528 B-treatment
; 128 129 528 529 O
surgical 130 138 530 538 B-treatment
removal 139 146 539 546 I-treatment
with 147 151 547 551 O
minimal 152 159 552 559 O
morbidity 160 169 560 569 O
( 170 171 570 571 O
defined 171 178 571 578 O
as 179 181 579 581 O
any 182 185 582 585 O
procedure 186 195 586 595 O
for 196 199 596 599 O
which 200 205 600 605 O
expected 206 214 606 614 O
hospitalization 215 230 615 630 O
is 231 233 631 633 O
≤ 234 235 634 635 O
3 236 237 636 637 B-upper_bound
days 238 242 638 642 I-upper_bound
) 242 243 642 643 O

Bilateral 0 9 644 653 O
tubal 10 15 654 659 B-treatment
occlusion 16 25 660 669 I-treatment

Chemotherapy 0 12 670 682 B-treatment

Estimated 0 9 683 692 B-clinical_variable
creatinine 10 20 693 703 I-clinical_variable
clearance 21 30 704 713 I-clinical_variable
( 31 32 714 715 I-clinical_variable
eCrCl 32 37 715 720 I-clinical_variable
) 37 38 720 721 I-clinical_variable
≥ 39 40 722 723 O
40 41 43 724 726 B-lower_bound
mL 44 46 727 729 I-lower_bound
/ 46 47 729 730 I-lower_bound
min 47 50 730 733 I-lower_bound
using 51 56 734 739 O
the 57 60 740 743 O
Cockcroft 61 70 744 753 O
- 70 71 753 754 O
Gault 71 76 754 759 O
formula 77 84 760 767 O

Hemoglobin 0 10 768 778 B-clinical_variable
( 11 12 779 780 I-clinical_variable
Hb 12 14 780 782 I-clinical_variable
) 14 15 782 783 I-clinical_variable
≥ 16 17 784 785 O
9.0 18 21 786 789 B-lower_bound
g 22 23 790 791 I-lower_bound
/ 23 24 791 792 I-lower_bound
dL 24 26 792 794 I-lower_bound

Immunotherapy 0 13 795 808 B-treatment
: 13 14 808 809 O
anti 15 19 810 814 B-treatment
- 19 20 814 815 I-treatment
cytotoxic 20 29 815 824 I-treatment
T 30 31 825 826 I-treatment
lymphocyte 32 42 827 837 I-treatment
- 42 43 837 838 I-treatment
associated 43 53 838 848 I-treatment
antigen 54 61 849 856 I-treatment
4 62 63 857 858 I-treatment
( 64 65 859 860 I-treatment
CTLA-4)/anti 65 77 860 872 I-treatment
- 77 78 872 873 I-treatment
PD-1 78 82 873 877 I-treatment
, 82 83 877 878 O
other 84 89 879 884 B-treatment
monoclonal 90 100 885 895 I-treatment
antibody 101 109 896 904 I-treatment
( 110 111 905 906 I-treatment
mAb 111 114 906 909 I-treatment
) 114 115 909 910 I-treatment
, 115 116 910 911 O
or 117 119 912 914 O
vaccine 120 127 915 922 B-treatment

Intrauterine 0 12 923 935 B-contraception_consent
device 13 19 936 942 I-contraception_consent
( 20 21 943 944 I-contraception_consent
IUD 21 24 944 947 I-contraception_consent
) 24 25 947 948 I-contraception_consent

Intrauterine 0 12 949 961 B-treatment
hormone 13 20 962 969 I-treatment
- 20 21 969 970 I-treatment
releasing 21 30 970 979 I-treatment
system 31 37 980 986 I-treatment
( 38 39 987 988 I-treatment
IUS 39 42 988 991 I-treatment
) 42 43 991 992 I-treatment

Lesions 0 7 993 1000 O
in 8 10 1001 1003 O
previously 11 21 1004 1014 O
irradiated 22 32 1015 1025 O
areas 33 38 1026 1031 O
( 39 40 1032 1033 O
or 40 42 1033 1035 O
other 43 48 1036 1041 O
local 49 54 1042 1047 B-treatment
therapy 55 62 1048 1055 I-treatment
) 62 63 1055 1056 O
should 64 70 1057 1063 O
not 71 74 1064 1067 O
be 75 77 1068 1070 O
selected 78 86 1071 1079 O
as 87 89 1080 1082 O
target 90 96 1083 1089 O
lesions 97 104 1090 1097 O
, 104 105 1097 1098 O
unless 106 112 1099 1105 O
treatment 113 122 1106 1115 B-treatment
was 123 126 1116 1119 O
≥ 127 128 1120 1121 O
3 129 130 1122 1123 B-lower_bound
months 131 137 1124 1130 I-lower_bound
prior 138 143 1131 1136 I-lower_bound
to 144 146 1137 1139 O
Screening 147 156 1140 1149 O
, 156 157 1149 1150 O
and 158 161 1151 1154 O
there 162 167 1155 1160 O
has 168 171 1161 1164 O
been 172 176 1165 1169 O
demonstrated 177 189 1170 1182 O
disease 190 197 1183 1190 O
progression 198 209 1191 1202 O
in 210 212 1203 1205 O
that 213 217 1206 1210 O
particular 218 228 1211 1221 O
lesion 229 235 1222 1228 O

NMA 0 3 1229 1232 B-treatment
- 3 4 1232 1233 I-treatment
LD 4 6 1233 1235 I-treatment
preconditioning 7 22 1236 1251 I-treatment
regimen 23 30 1252 1259 I-treatment
( 31 32 1260 1261 O
cyclophosphamide 32 48 1261 1277 B-treatment
, 48 49 1277 1278 O
mesna 50 55 1279 1284 B-treatment
, 55 56 1284 1285 O
and 57 60 1286 1289 O
fludarabine 61 72 1290 1301 B-treatment
) 72 73 1301 1302 O

Palliative 0 10 1303 1313 B-treatment
radiation 11 20 1314 1323 I-treatment
therapy 21 28 1324 1331 I-treatment
is 29 31 1332 1334 O
permitted 32 41 1335 1344 O
so 42 44 1345 1347 O
long 45 49 1348 1352 O
as 50 52 1353 1355 O
it 53 55 1356 1358 O
does 56 60 1359 1363 O
not 61 64 1364 1367 O
involve 65 72 1368 1375 O
lesions 73 80 1376 1383 B-cancer
being 81 86 1384 1389 O
selected 87 95 1390 1398 O
for 96 99 1399 1402 O
TIL 100 103 1403 1406 B-cancer
, 103 104 1406 1407 O
or 105 107 1408 1410 O
as 108 110 1411 1413 O
target 111 117 1414 1420 B-cancer
or 118 120 1421 1423 I-cancer
non 121 124 1424 1427 I-cancer
- 124 125 1427 1428 I-cancer
target 125 131 1428 1434 I-cancer
lesions 132 139 1435 1442 I-cancer
. 139 140 1442 1443 O
Washout 141 148 1444 1451 O
is 149 151 1452 1454 O
not 152 155 1455 1458 O
required 156 164 1459 1467 O
if 165 167 1468 1470 O
all 168 171 1471 1474 O
related 172 179 1475 1482 O
toxicities 180 190 1483 1493 B-clinical_variable
have 191 195 1494 1498 O
resolved 196 204 1499 1507 O
to 205 207 1508 1510 O
≤ 208 209 1511 1512 O
Grade 210 215 1513 1518 B-upper_bound
1 216 217 1519 1520 I-upper_bound
as 218 220 1521 1523 O
per 221 224 1524 1527 O
CTCAE 225 230 1528 1533 O
v4.03 231 236 1534 1539 O

Patients 0 8 1540 1548 O
must 9 13 1549 1553 O
be 14 16 1554 1556 O
≥ 17 18 1557 1558 O
18 19 21 1559 1561 B-lower_bound
years 22 27 1562 1567 I-lower_bound
of 28 30 1568 1570 O
age 31 34 1571 1574 B-age
at 35 37 1575 1577 O
the 38 41 1578 1581 O
time 42 46 1582 1586 O
of 47 49 1587 1589 O
consent 50 57 1590 1597 O
. 57 58 1597 1598 O
Enrollment 59 69 1599 1609 O
of 70 72 1610 1612 O
patients 73 81 1613 1621 O
> 82 83 1622 1623 O
70 84 86 1624 1626 B-lower_bound
years 87 92 1627 1632 I-lower_bound
of 93 95 1633 1635 O
age 96 99 1636 1639 O
may 100 103 1640 1643 O
be 104 106 1644 1646 O
allowed 107 114 1647 1654 O
after 115 120 1655 1660 O
consultation 121 133 1661 1673 O
with 134 138 1674 1678 O
the 139 142 1679 1682 O
Medical 143 150 1683 1690 O
Monitor 151 158 1691 1698 O

Patients 0 8 1699 1707 O
must 9 13 1708 1712 O
have 14 18 1713 1717 O
a 19 20 1718 1719 O
washout 21 28 1720 1727 B-clinical_variable
period 29 35 1728 1734 I-clinical_variable
≥ 36 37 1735 1736 O
28 38 40 1737 1739 B-lower_bound
days 41 45 1740 1744 I-lower_bound
from 46 50 1745 1749 O
prior 51 56 1750 1755 B-treatment
anticancer 57 67 1756 1766 I-treatment
therapy(ies 68 79 1767 1778 I-treatment
) 79 80 1778 1779 I-treatment
to 81 83 1780 1782 O
the 84 87 1783 1786 O
start 88 93 1787 1792 O
of 94 96 1793 1795 O
the 97 100 1796 1799 O
planned 101 108 1800 1807 O
NMA 109 112 1808 1811 B-treatment
- 112 113 1811 1812 I-treatment
LD 113 115 1812 1814 I-treatment
preconditioning 116 131 1815 1830 I-treatment
regimen 132 139 1831 1838 I-treatment

Patients 0 8 1839 1847 O
must 9 13 1848 1852 O
have 14 18 1853 1857 O
an 19 21 1858 1860 O
Eastern 22 29 1861 1868 B-clinical_variable
Cooperative 30 41 1869 1880 I-clinical_variable
Oncology 42 50 1881 1889 I-clinical_variable
Group 51 56 1890 1895 I-clinical_variable
( 57 58 1896 1897 I-clinical_variable
ECOG 58 62 1897 1901 I-clinical_variable
) 62 63 1901 1902 I-clinical_variable
performance 64 75 1903 1914 I-clinical_variable
status 76 82 1915 1921 I-clinical_variable
of 83 85 1922 1924 O
0 86 87 1925 1926 B-lower_bound
or 88 90 1927 1929 O
1 91 92 1930 1931 B-upper_bound
and 93 96 1932 1935 O
an 97 99 1936 1938 O
estimated 100 109 1939 1948 O
life 110 114 1949 1953 B-clinical_variable
expectancy 115 125 1954 1964 I-clinical_variable
of 126 128 1965 1967 O
≥ 129 130 1968 1969 O
3 131 132 1970 1971 B-lower_bound
months 133 139 1972 1978 I-lower_bound

Patients 0 8 1979 1987 O
must 9 13 1988 1992 O
have 14 18 1993 1997 O
progressed 19 29 1998 2008 O
following 30 39 2009 2018 O
≥ 40 41 2019 2020 O
one 42 45 2021 2024 B-lower_bound
prior 46 51 2025 2030 B-treatment
systemic 52 60 2031 2039 I-treatment
therapy 61 68 2040 2047 I-treatment
including 69 78 2048 2057 I-treatment
a 79 80 2058 2059 I-treatment
programmed 81 91 2060 2070 I-treatment
cell 92 96 2071 2075 I-treatment
death 97 102 2076 2081 I-treatment
protein-1 103 112 2082 2091 I-treatment
( 113 114 2092 2093 I-treatment
PD-1 114 118 2093 2097 I-treatment
) 118 119 2097 2098 I-treatment
blocking 120 128 2099 2107 I-treatment
antibody 129 137 2108 2116 I-treatment
; 137 138 2116 2117 O
and 139 142 2118 2121 O
if 143 145 2122 2124 O
proto 146 151 2125 2130 O
- 151 152 2130 2131 O
oncogene 152 160 2131 2139 O
B 161 162 2140 2141 O
- 162 163 2141 2142 O
Raf 163 166 2142 2145 O
( 167 168 2146 2147 O
BRAF 168 172 2147 2151 O
) 172 173 2151 2152 O
V600 174 178 2153 2157 O
mutation 179 187 2158 2166 O
- 187 188 2166 2167 O
positive 188 196 2167 2175 O
, 196 197 2175 2176 O
a 198 199 2177 2178 O
BRAF 200 204 2179 2183 B-treatment
inhibitor 205 214 2184 2193 I-treatment
or 215 217 2194 2196 O
BRAF 218 222 2197 2201 B-treatment
inhibitor 223 232 2202 2211 I-treatment
in 233 235 2212 2214 I-treatment
combination 236 247 2215 2226 I-treatment
with 248 252 2227 2231 I-treatment
mitogen 253 260 2232 2239 I-treatment
- 260 261 2239 2240 I-treatment
activated 261 270 2240 2249 I-treatment
extracellular 271 284 2250 2263 I-treatment
signal 285 291 2264 2270 I-treatment
- 291 292 2270 2271 I-treatment
regulated 292 301 2271 2280 I-treatment
kinase 302 308 2281 2287 I-treatment
( 309 310 2288 2289 I-treatment
MEK 310 313 2289 2292 I-treatment
) 313 314 2292 2293 I-treatment
inhibitor 315 324 2294 2303 I-treatment

Patients 0 8 2304 2312 O
must 9 13 2313 2317 O
have 14 18 2318 2322 O
recovered 19 28 2323 2332 O
from 29 33 2333 2337 O
all 34 37 2338 2341 O
prior 38 43 2342 2347 B-treatment
therapy 44 51 2348 2355 I-treatment
- 51 52 2355 2356 O
related 52 59 2356 2363 O
adverse 60 67 2364 2371 O
events 68 74 2372 2378 O
( 75 76 2379 2380 O
AEs 76 79 2380 2383 O
) 79 80 2383 2384 O
to 81 83 2385 2387 O
≤ 84 85 2388 2389 O
Grade 86 91 2390 2395 B-upper_bound
1 92 93 2396 2397 I-upper_bound
( 94 95 2398 2399 O
per 95 98 2399 2402 O
Common 99 105 2403 2409 O
Terminology 106 117 2410 2421 O
Criteria 118 126 2422 2430 O
for 127 130 2431 2434 O
Adverse 131 138 2435 2442 O
Events 139 145 2443 2449 O
[ 146 147 2450 2451 O
CTCAE 147 152 2451 2456 O
] 152 153 2456 2457 O
v4.03 154 159 2458 2463 O
) 159 160 2463 2464 O
, 160 161 2464 2465 O
except 162 168 2466 2472 O
for 169 172 2473 2476 O
alopecia 173 181 2477 2485 B-chronic_disease
or 182 184 2486 2488 O
vitiligo 185 193 2489 2497 B-chronic_disease
, 193 194 2497 2498 O
prior 195 200 2499 2504 O
to 201 203 2505 2507 O
Enrollment 204 214 2508 2518 O
( 215 216 2519 2520 O
tumor 216 221 2520 2525 B-treatment
resection 222 231 2526 2535 I-treatment
) 231 232 2535 2536 O

Patients 0 8 2537 2545 O
of 9 11 2546 2548 O
childbearing 12 24 2549 2561 O
potential 25 34 2562 2571 O
or 35 37 2572 2574 O
their 38 43 2575 2580 O
partners 44 52 2581 2589 O
of 53 55 2590 2592 O
childbearing 56 68 2593 2605 O
potential 69 78 2606 2615 O
must 79 83 2616 2620 O
be 84 86 2621 2623 O
willing 87 94 2624 2631 B-contraception_consent
to 95 97 2632 2634 I-contraception_consent
take 98 102 2635 2639 I-contraception_consent
the 103 106 2640 2643 I-contraception_consent
appropriate 107 118 2644 2655 I-contraception_consent
precaution 119 129 2656 2666 I-contraception_consent
to 130 132 2667 2669 I-contraception_consent
avoid 133 138 2670 2675 I-contraception_consent
pregnancy 139 148 2676 2685 I-contraception_consent
or 149 151 2686 2688 I-contraception_consent
fathering 152 161 2689 2698 I-contraception_consent
a 162 163 2699 2700 I-contraception_consent
child 164 169 2701 2706 I-contraception_consent
for 170 173 2707 2710 O
the 174 177 2711 2714 O
duration 178 186 2715 2723 O
of 187 189 2724 2726 O
the 190 193 2727 2730 O
study 194 199 2731 2736 O
and 200 203 2737 2740 O
practice 204 212 2741 2749 O
an 213 215 2750 2752 O
approved 216 224 2753 2761 O
, 224 225 2761 2762 O
highly 226 232 2763 2769 B-contraception_consent
effective 233 242 2770 2779 I-contraception_consent
method 243 249 2780 2786 I-contraception_consent
of 250 252 2787 2789 I-contraception_consent
birth 253 258 2790 2795 I-contraception_consent
control 259 266 2796 2803 I-contraception_consent
during 267 273 2804 2810 O
treatment 274 283 2811 2820 B-treatment
and 284 287 2821 2824 O
for 288 291 2825 2828 O
12 292 294 2829 2831 B-upper_bound
months 295 301 2832 2838 I-upper_bound
after 302 307 2839 2844 I-upper_bound
receiving 308 317 2845 2854 O
the 318 321 2855 2858 O
last 322 326 2859 2863 O
protocol 327 335 2864 2872 O
- 335 336 2872 2873 O
related 336 343 2873 2880 O
therapy 344 351 2881 2888 B-treatment

Patients 0 8 2889 2897 O
who 9 12 2898 2901 O
are 13 16 2902 2905 O
on 17 19 2906 2908 O
chronic 20 27 2909 2916 B-treatment
systemic 28 36 2917 2925 I-treatment
steroid 37 44 2926 2933 I-treatment
therapy 45 52 2934 2941 I-treatment
for 53 56 2942 2945 O
any 57 60 2946 2949 O
reason 61 67 2950 2956 O

Patients 0 8 2957 2965 O
who 9 12 2966 2969 O
are 13 16 2970 2973 O
pregnant 17 25 2974 2982 B-pregnancy
or 26 28 2983 2985 O
breastfeeding 29 42 2986 2999 O

Patients 0 8 3000 3008 O
who 9 12 3009 3012 O
have 13 17 3013 3017 O
a 18 19 3018 3019 O
documented 20 30 3020 3030 O
forced 31 37 3031 3037 O
expiratory 38 48 3038 3048 O
volume 49 55 3049 3055 O
in 56 58 3056 3058 O
1 59 60 3059 3060 O
second 61 67 3061 3067 O
( 68 69 3068 3069 O
FEV1 69 73 3069 3073 B-clinical_variable
) 73 74 3073 3074 O
of 75 77 3075 3077 O
≤ 78 79 3078 3079 O
60 80 82 3080 3082 B-upper_bound
% 82 83 3082 3083 I-upper_bound

Patients 0 8 3084 3092 O
who 9 12 3093 3096 O
have 13 17 3097 3101 O
a 18 19 3102 3103 O
history 20 27 3104 3111 O
of 28 30 3112 3114 O
hypersensitivity 31 47 3115 3131 O
to 48 50 3132 3134 O
any 51 54 3135 3138 O
component 55 64 3139 3148 O
or 65 67 3149 3151 O
excipient 68 77 3152 3161 O
of 78 80 3162 3164 O
LN-144 81 87 3165 3171 B-allergy_name
or 88 90 3172 3174 O
other 91 96 3175 3180 O
study 97 102 3181 3186 B-allergy_name
drugs 103 108 3187 3192 I-allergy_name

Patients 0 8 3193 3201 O
who 9 12 3202 3205 O
have 13 17 3206 3210 O
a 18 19 3211 3212 O
left 20 24 3213 3217 B-clinical_variable
ventricular 25 36 3218 3229 I-clinical_variable
ejection 37 45 3230 3238 I-clinical_variable
fraction 46 54 3239 3247 I-clinical_variable
( 55 56 3248 3249 I-clinical_variable
LVEF 56 60 3249 3253 I-clinical_variable
) 60 61 3253 3254 I-clinical_variable
< 62 63 3255 3256 O
45 64 66 3257 3259 B-upper_bound
% 66 67 3259 3260 I-upper_bound
or 68 70 3261 3263 O
New 71 74 3264 3267 B-clinical_variable
York 75 79 3268 3272 I-clinical_variable
Heart 80 85 3273 3278 I-clinical_variable
Association 86 97 3279 3290 I-clinical_variable
( 98 99 3291 3292 I-clinical_variable
NYHA 99 103 3292 3296 I-clinical_variable
) 103 104 3296 3297 I-clinical_variable
functional 105 115 3298 3308 I-clinical_variable
classification 116 130 3309 3323 I-clinical_variable
> 131 132 3324 3325 O
Class 133 138 3326 3331 B-lower_bound
1 139 140 3332 3333 I-lower_bound

Patients 0 8 3334 3342 O
who 9 12 3343 3346 O
have 13 17 3347 3351 O
active 18 24 3352 3358 O
medical 25 32 3359 3366 O
illness(es 33 43 3367 3377 O
) 43 44 3377 3378 O
that 45 49 3379 3383 O
would 50 55 3384 3389 O
pose 56 60 3390 3394 O
increased 61 70 3395 3404 O
risk 71 75 3405 3409 O
for 76 79 3410 3413 O
study 80 85 3414 3419 O
participation 86 99 3420 3433 O
, 99 100 3433 3434 O
including 101 110 3435 3444 O
: 110 111 3444 3445 O
active 112 118 3446 3452 B-chronic_disease
systemic 119 127 3453 3461 I-chronic_disease
infections 128 138 3462 3472 I-chronic_disease
requiring 139 148 3473 3482 O
systemic 149 157 3483 3491 B-treatment
ABX 158 161 3492 3495 I-treatment
, 161 162 3495 3496 O
coagulation 163 174 3497 3508 B-chronic_disease
disorders 175 184 3509 3518 I-chronic_disease
, 184 185 3518 3519 O
or 186 188 3520 3522 O
other 189 194 3523 3528 O
active 195 201 3529 3535 O
major 202 207 3536 3541 O
medical 208 215 3542 3549 O
illnesses 216 225 3550 3559 O
of 226 228 3560 3562 O
the 229 232 3563 3566 O
cardiovascular 233 247 3567 3581 O
, 247 248 3581 3582 O
respiratory 249 260 3583 3594 O
, 260 261 3594 3595 O
or 262 264 3596 3598 O
immune 265 271 3599 3605 O
system 272 278 3606 3612 O

Patients 0 8 3613 3621 O
who 9 12 3622 3625 O
have 13 17 3626 3630 O
any 18 21 3631 3634 O
form 22 26 3635 3639 O
of 27 29 3640 3642 O
primary 30 37 3643 3650 O
immunodeficiency 38 54 3651 3667 B-chronic_disease
( 55 56 3668 3669 O
such 56 60 3669 3673 O
as 61 63 3674 3676 O
severe 64 70 3677 3683 B-chronic_disease
combined 71 79 3684 3692 I-chronic_disease
immunodeficiency 80 96 3693 3709 I-chronic_disease
disease 97 104 3710 3717 I-chronic_disease
[ 105 106 3718 3719 I-chronic_disease
SCID 106 110 3719 3723 I-chronic_disease
] 110 111 3723 3724 I-chronic_disease
and 112 115 3725 3728 O
acquired 116 124 3729 3737 B-chronic_disease
immunodeficiency 125 141 3738 3754 I-chronic_disease
syndrome 142 150 3755 3763 I-chronic_disease
[ 151 152 3764 3765 I-chronic_disease
AIDS 152 156 3765 3769 I-chronic_disease
] 156 157 3769 3770 I-chronic_disease
) 157 158 3770 3771 O

Patients 0 8 3772 3780 O
who 9 12 3781 3784 O
have 13 17 3785 3789 O
been 18 22 3790 3794 O
shown 23 28 3795 3800 O
to 29 31 3801 3803 O
be 32 34 3804 3806 O
BRAF 35 39 3807 3811 O
mutation 40 48 3812 3820 O
positive 49 57 3821 3829 O
( 58 59 3830 3831 O
V600 59 63 3831 3835 O
) 63 64 3835 3836 O
, 64 65 3836 3837 O
but 66 69 3838 3841 O
have 70 74 3842 3846 O
not 75 78 3847 3850 O
received 79 87 3851 3859 O
prior 88 93 3860 3865 B-treatment
systemic 94 102 3866 3874 I-treatment
therapy 103 110 3875 3882 I-treatment
with 111 115 3883 3887 I-treatment
a 116 117 3888 3889 I-treatment
BRAF 118 122 3890 3894 I-treatment
inhibitor 123 132 3895 3904 I-treatment
alone 133 138 3905 3910 I-treatment
or 139 141 3911 3913 O
a 142 143 3914 3915 O
BRAF 144 148 3916 3920 B-treatment
inhibitor 149 158 3921 3930 I-treatment
in 159 161 3931 3933 I-treatment
combination 162 173 3934 3945 I-treatment
with 174 178 3946 3950 I-treatment
a 179 180 3951 3952 I-treatment
MEK 181 184 3953 3956 I-treatment
inhibitor 185 194 3957 3966 I-treatment

Patients 0 8 3967 3975 O
who 9 12 3976 3979 O
have 13 17 3980 3984 O
had 18 21 3985 3988 O
another 22 29 3989 3996 O
primary 30 37 3997 4004 B-cancer
malignancy 38 48 4005 4015 I-cancer
within 49 55 4016 4022 O
the 56 59 4023 4026 O
previous 60 68 4027 4035 B-upper_bound
3 69 70 4036 4037 I-upper_bound
years 71 76 4038 4043 I-upper_bound
( 77 78 4044 4045 O
with 78 82 4045 4049 O
the 83 86 4050 4053 O
exception 87 96 4054 4063 O
of 97 99 4064 4066 O
carcinoma 100 109 4067 4076 B-cancer
in 110 112 4077 4079 I-cancer
situ 113 117 4080 4084 I-cancer
of 118 120 4085 4087 I-cancer
the 121 124 4088 4091 I-cancer
breast 125 131 4092 4098 I-cancer
, 131 132 4098 4099 O
cervix 133 139 4100 4106 B-cancer
, 139 140 4106 4107 O
or 141 143 4108 4110 O
bladder 144 151 4111 4118 B-cancer
; 151 152 4118 4119 O
localized 153 162 4120 4129 B-cancer
prostate 163 171 4130 4138 I-cancer
cancer 172 178 4139 4145 I-cancer
; 178 179 4145 4146 O
and 180 183 4147 4150 O
non 184 187 4151 4154 B-cancer
- 187 188 4154 4155 I-cancer
melanoma 188 196 4155 4163 I-cancer
skin 197 201 4164 4168 I-cancer
cancer 202 208 4169 4175 I-cancer
that 209 213 4176 4180 O
has 214 217 4181 4184 O
been 218 222 4185 4189 O
adequately 223 233 4190 4200 O
treated 234 241 4201 4208 O
) 241 242 4208 4209 O

Patients 0 8 4210 4218 O
who 9 12 4219 4222 O
have 13 17 4223 4227 O
received 18 26 4228 4236 O
a 27 28 4237 4238 O
live 29 33 4239 4243 B-treatment
or 34 36 4244 4246 I-treatment
attenuated 37 47 4247 4257 I-treatment
vaccine 48 55 4258 4265 I-treatment
within 56 62 4266 4272 O
28 63 65 4273 4275 B-upper_bound
days 66 70 4276 4280 I-upper_bound
of 71 73 4281 4283 O
beginning 74 83 4284 4293 O
the 84 87 4294 4297 O
NMA 88 91 4298 4301 B-treatment
- 91 92 4301 4302 I-treatment
LD 92 94 4302 4304 I-treatment
preconditioning 95 110 4305 4320 I-treatment
regimen 111 118 4321 4328 I-treatment

Patients 0 8 4329 4337 O
who 9 12 4338 4341 O
have 13 17 4342 4346 O
received 18 26 4347 4355 O
an 27 29 4356 4358 O
organ 30 35 4359 4364 O
allograft 36 45 4365 4374 B-treatment
or 46 48 4375 4377 O
prior 49 54 4378 4383 B-treatment
cell 55 59 4384 4388 I-treatment
transfer 60 68 4389 4397 I-treatment
therapy 69 76 4398 4405 I-treatment

Patients 0 8 4406 4414 O
whose 9 14 4415 4420 O
cancer 15 21 4421 4427 B-cancer
requires 22 30 4428 4436 O
immediate 31 40 4437 4446 O
attention 41 50 4447 4456 O
or 51 53 4457 4459 O
who 54 57 4460 4463 O
would 58 63 4464 4469 O
otherwise 64 73 4470 4479 O
suffer 74 80 4480 4486 O
a 81 82 4487 4488 O
disadvantage 83 95 4489 4501 O
by 96 98 4502 4504 O
participating 99 112 4505 4518 O
in 113 115 4519 4521 O
this 116 120 4522 4526 O
trial 121 126 4527 4532 O

Patients 0 8 4533 4541 O
with 9 13 4542 4546 O
Gilbert 14 21 4547 4554 B-chronic_disease
's 21 23 4554 4556 I-chronic_disease
syndrome 24 32 4557 4565 I-chronic_disease
must 33 37 4566 4570 O
have 38 42 4571 4575 O
a 43 44 4576 4577 O
total 45 50 4578 4583 B-clinical_variable
bilirubin 51 60 4584 4593 I-clinical_variable
≤ 61 62 4594 4595 O
3 63 64 4596 4597 B-upper_bound
mg 65 67 4598 4600 I-upper_bound
/ 67 68 4600 4601 I-upper_bound
dL 68 70 4601 4603 I-upper_bound

Patients 0 8 4604 4612 O
with 9 13 4613 4617 O
definitively 14 26 4618 4630 O
treated 27 34 4631 4638 O
brain 35 40 4639 4644 B-cancer
metastases 41 51 4645 4655 I-cancer
may 52 55 4656 4659 O
be 56 58 4660 4662 O
considered 59 69 4663 4673 O
for 70 73 4674 4677 O
Enrollment 74 84 4678 4688 O
, 84 85 4688 4689 O
and 86 89 4690 4693 O
must 90 94 4694 4698 O
be 95 97 4699 4701 O
stable 98 104 4702 4708 O
for 105 108 4709 4712 O
≥ 109 110 4713 4714 O
14 111 113 4715 4717 B-lower_bound
days 114 118 4718 4722 I-lower_bound
prior 119 124 4723 4728 I-lower_bound
to 125 127 4729 4731 O
beginning 128 137 4732 4741 O
the 138 141 4742 4745 O
NMA 142 145 4746 4749 O
LD 146 148 4750 4752 O
preconditioning 149 164 4753 4768 O
regimen 165 172 4769 4776 O

Patients 0 8 4777 4785 O
with 9 13 4786 4790 O
documented 14 24 4791 4801 O
≥ 25 26 4802 4803 O
Grade 27 32 4804 4809 B-lower_bound
2 33 34 4810 4811 I-lower_bound
diarrhea 35 43 4812 4820 I-lower_bound
or 44 46 4821 4823 O
colitis 47 54 4824 4831 B-chronic_disease
as 55 57 4832 4834 O
a 58 59 4835 4836 O
result 60 66 4837 4843 O
of 67 69 4844 4846 O
previous 70 78 4847 4855 B-treatment
treatment 79 88 4856 4865 I-treatment
with 89 93 4866 4870 I-treatment
immune 94 100 4871 4877 I-treatment
checkpoint 101 111 4878 4888 I-treatment
inhibitor(s 112 123 4889 4900 I-treatment
) 123 124 4900 4901 I-treatment
must 125 129 4902 4906 O
have 130 134 4907 4911 O
been 135 139 4912 4916 O
asymptomatic 140 152 4917 4929 O
for 153 156 4930 4933 O
at 157 159 4934 4936 O
least 160 165 4937 4942 O
6 166 167 4943 4944 B-lower_bound
months 168 174 4945 4951 I-lower_bound
and/or 175 181 4952 4958 O
had 182 185 4959 4962 O
a 186 187 4963 4964 O
normal 188 194 4965 4971 O
colonoscopy 195 206 4972 4983 B-treatment
post 207 211 4984 4988 O
- 211 212 4988 4989 O
immune 212 218 4989 4995 O
checkpoint 219 229 4996 5006 O
inhibitor 230 239 5007 5016 B-treatment
treatment 240 249 5017 5026 I-treatment
, 249 250 5026 5027 O
by 251 253 5028 5030 O
visual 254 260 5031 5037 O
assessment 261 271 5038 5048 O
, 271 272 5048 5049 O
prior 273 278 5050 5055 O
to 279 281 5056 5058 O
tumor 282 287 5059 5064 B-treatment
resection 288 297 5065 5074 I-treatment

Patients 0 8 5075 5083 O
with 9 13 5084 5088 O
melanoma 14 22 5089 5097 B-cancer
of 23 25 5098 5100 I-cancer
uveal 26 31 5101 5106 I-cancer
/ 31 32 5106 5107 I-cancer
ocular 32 38 5107 5113 I-cancer
origin 39 45 5114 5120 O

Patients 0 8 5121 5129 O
with 9 13 5130 5134 O
symptomatic 14 25 5135 5146 O
and/or 26 32 5147 5153 O
untreated 33 42 5154 5163 O
brain 43 48 5164 5169 B-cancer
metastases 49 59 5170 5180 I-cancer
( 60 61 5181 5182 O
of 61 63 5182 5184 O
any 64 67 5185 5188 O
size 68 72 5189 5193 O
and 73 76 5194 5197 O
any 77 80 5198 5201 O
number 81 87 5202 5208 O
) 87 88 5208 5209 O

Patients 0 8 5210 5218 O
with 9 13 5219 5223 O
unresectable 14 26 5224 5236 O
or 27 29 5237 5239 O
metastatic 30 40 5240 5250 B-cancer
melanoma 41 49 5251 5259 I-cancer
( 50 51 5260 5261 O
Stage 51 56 5261 5266 B-lower_bound
IIIc 57 61 5267 5271 I-lower_bound
or 62 64 5272 5274 O
Stage 65 70 5275 5280 B-upper_bound
IV 71 73 5281 5283 I-upper_bound
) 73 74 5283 5284 O

Patients 0 8 5285 5293 O
≥ 9 10 5294 5295 O
60 11 13 5296 5298 B-lower_bound
years 14 19 5299 5304 I-lower_bound
of 20 22 5305 5307 O
age 23 26 5308 5311 B-age
and 27 30 5312 5315 O
who 31 34 5316 5319 O
have 35 39 5320 5324 O
a 40 41 5325 5326 O
history 42 49 5327 5334 O
of 50 52 5335 5337 O
ischemic 53 61 5338 5346 B-chronic_disease
heart 62 67 5347 5352 I-chronic_disease
disease 68 75 5353 5360 I-chronic_disease
, 75 76 5360 5361 O
chest 77 82 5362 5367 B-chronic_disease
pain 83 87 5368 5372 I-chronic_disease
, 87 88 5372 5373 O
or 89 91 5374 5376 O
clinically 92 102 5377 5387 O
significant 103 114 5388 5399 O
atrial 115 121 5400 5406 O
and/or 122 128 5407 5413 O
ventricular 129 140 5414 5425 B-chronic_disease
arrhythmias 141 152 5426 5437 I-chronic_disease
must 153 157 5438 5442 O
have 158 162 5443 5447 O
a 163 164 5448 5449 O
cardiac 165 172 5450 5457 O
stress 173 179 5458 5464 O
test 180 184 5465 5469 O
. 184 185 5469 5470 O
Patients 186 194 5471 5479 O
with 195 199 5480 5484 O
any 200 203 5485 5488 O
irreversible 204 216 5489 5501 O
wall 217 221 5502 5506 O
movement 222 230 5507 5515 O
abnormalities 231 244 5516 5529 O

Platelet 0 8 5530 5538 B-clinical_variable
≥ 9 10 5539 5540 O
100,000 11 18 5541 5548 B-lower_bound
/ 18 19 5548 5549 I-lower_bound
mm3 19 22 5549 5552 I-lower_bound

Serum 0 5 5553 5558 B-clinical_variable
alanine 6 13 5559 5566 I-clinical_variable
transaminase 14 26 5567 5579 I-clinical_variable
( 27 28 5580 5581 I-clinical_variable
ALT)/serum 28 38 5581 5591 I-clinical_variable
glutamic 39 47 5592 5600 I-clinical_variable
- 47 48 5600 5601 I-clinical_variable
pyruvic 48 55 5601 5608 I-clinical_variable
transaminase 56 68 5609 5621 I-clinical_variable
( 69 70 5622 5623 I-clinical_variable
SGPT 70 74 5623 5627 I-clinical_variable
) 74 75 5627 5628 I-clinical_variable
and 76 79 5629 5632 O
aspartate 80 89 5633 5642 B-clinical_variable
transaminase 90 102 5643 5655 I-clinical_variable
( 103 104 5656 5657 I-clinical_variable
AST)/serum 104 114 5657 5667 I-clinical_variable
glutamic 115 123 5668 5676 I-clinical_variable
- 123 124 5676 5677 I-clinical_variable
oxaloacetic 124 135 5677 5688 I-clinical_variable
transaminase 136 148 5689 5701 I-clinical_variable
( 149 150 5702 5703 I-clinical_variable
SGOT 150 154 5703 5707 I-clinical_variable
) 154 155 5707 5708 I-clinical_variable
≤ 156 157 5709 5710 O
3 158 159 5711 5712 B-upper_bound
times 160 165 5713 5718 I-upper_bound
the 166 169 5719 5722 I-upper_bound
upper 170 175 5723 5728 I-upper_bound
limit 176 181 5729 5734 I-upper_bound
of 182 184 5735 5737 I-upper_bound
normal 185 191 5738 5744 I-upper_bound
( 192 193 5745 5746 I-upper_bound
ULN 193 196 5746 5749 I-upper_bound
) 196 197 5749 5750 I-upper_bound
; 197 198 5750 5751 O
patients 199 207 5752 5760 O
with 208 212 5761 5765 O
liver 213 218 5766 5771 B-clinical_variable
metastasis 219 229 5772 5782 I-clinical_variable
≤ 230 231 5783 5784 O
5 232 233 5785 5786 B-upper_bound
times 234 239 5787 5792 I-upper_bound
ULN 240 243 5793 5796 I-upper_bound

Targeted 0 8 5797 5805 B-treatment
therapy 9 16 5806 5813 I-treatment
: 16 17 5813 5814 O
MEK 18 21 5815 5818 B-treatment
/ 21 22 5818 5819 I-treatment
BRAF 22 26 5819 5823 I-treatment
or 27 29 5824 5826 O
other 30 35 5827 5832 O
targeted 36 44 5833 5841 B-treatment
agent 45 50 5842 5847 I-treatment

Total 0 5 5848 5853 B-clinical_variable
bilirubin 6 15 5854 5863 I-clinical_variable
≤ 16 17 5864 5865 O
2 18 19 5866 5867 B-upper_bound
mg 20 22 5868 5870 I-upper_bound
/ 22 23 5870 5871 I-upper_bound
dL 23 25 5871 5873 I-upper_bound

True 0 4 5874 5878 O
sexual 5 11 5879 5885 O
abstinence 12 22 5886 5896 O
when 23 27 5897 5901 O
this 28 32 5902 5906 O
is 33 35 5907 5909 O
in 36 38 5910 5912 O
line 39 43 5913 5917 O
with 44 48 5918 5922 O
the 49 52 5923 5926 O
preferred 53 62 5927 5936 O
and 63 66 5937 5940 O
usual 67 72 5941 5946 O
lifestyle 73 82 5947 5956 O
of 83 85 5957 5959 O
the 86 89 5960 5963 O
patient 90 97 5964 5971 O
. 97 98 5971 5972 O
Periodic 99 107 5973 5981 B-contraception_consent
abstinence 108 118 5982 5992 I-contraception_consent
( 119 120 5993 5994 I-contraception_consent
eg 120 122 5994 5996 I-contraception_consent
, 122 123 5996 5997 I-contraception_consent
calendar 124 132 5998 6006 I-contraception_consent
ovulation 133 142 6007 6016 I-contraception_consent
, 142 143 6016 6017 I-contraception_consent
symptothermal 144 157 6018 6031 I-contraception_consent
, 157 158 6031 6032 I-contraception_consent
post 159 163 6033 6037 I-contraception_consent
- 163 164 6037 6038 I-contraception_consent
ovulation 164 173 6038 6047 I-contraception_consent
methods 174 181 6048 6055 I-contraception_consent
) 181 182 6055 6056 I-contraception_consent
is 183 185 6057 6059 I-contraception_consent
not 186 189 6060 6063 I-contraception_consent
acceptable 190 200 6064 6074 I-contraception_consent

